A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

Clinical trial NCT04370405 · UNKNOWN

Trial details

NCT number: NCT04370405
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Follicular

Start date: 2019-04-29
Primary completion: 2020-11-30
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.